EC/EMA-FDA bilateraal overleg – update

Senior leadership from DG Health and Consumers (European Commission), the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) discussed a number of key initiatives at a bilateral meeting which took place in London from 31 March to 1 April 2014.
Participants discussed a broad range of issues, including drug supply-chain challenges and the creation of an EU-US Identification of Medicinal Products (IDMP) task force to explore the possibility of using and/or adapting the US new substances registration software for use in the EU, and to assess the feasibility of introducing global identification for medicinal products (EMA Nieuwsbericht, 22 april 2014).
Klik hier voor het volledige EMA Nieuwsbericht.

Dit bericht is ook opgenomen in ons maandelijkse overzicht, de NVC Members-only Update. Heeft u vragen, neem dan contact met ons op via e-mail of bel: +31-(0)182-512411.